Remdesivir for COVID-19: challenges of underpowered studies

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish
Pages (from-to)1-2
JournalThe Lancet
DOIs
Publication statusPublished - 29 Apr 2020

Cite this